This Study is to Evaluate Whether Receiving Education and Glucose Monitoring With the CGM Device Will Improve Patient-reported Outcomes by Improving Patient's Satisfaction and Quality of Life (QOL) With Glucose Monitoring Device
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Cedars-Sinai Medical Center
- Study ID
- NCT06965803
- Status
- Recruiting
Conditions
- Diabetes Mellitus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.
Key Dates
- Start date
- Oct 1, 2025
- Status verified
- Mar 2026
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2026
Study Design
- Enrollment
- 37 participants (estimated)
Primary Outcome Measure
Patient Satisfaction (using a 5-point likert scale) [ Time Frame: 15 days ]
Central Contacts
- Mathew P Monterola, Doctor of Nursing Practice3109677434
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cedars-Sina Medical Center | Los Angeles | California | 90048 | - |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Inflammation, Diabetes, Ethnicity and Obesity CohortRecruiting · University of California, San Francisco · San Francisco, California
- Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes MellitusNot Yet Recruiting · Bionime Corporation · Guntersville, Alabama
- Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney DiseaseEnrolling By Invitation · University of California, Irvine · Orange, California
- Increasing CGM Use Among Patients With T2DRecruiting · San Diego State University · El Centro, California